Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in ovarian cancers

Cancer Letters

Volumn 126, Issue 1, 1998, Pages 83-88

  Fujimoto, Jiro ^a   Ichigo, Satoshi ^a   Sakaguchi, Hideki ^a   Hirose, Reiko ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Neovascularization; Ovarian cancer; PD ECGF

Indexed keywords

MESSENGER RNA; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; CYSTADENOCARCINOMA; ENDOMETRIOID CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); OVARY CANCER; PRIORITY JOURNAL;

EID: 0344447107     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00537-5     Document Type: Article

References (25)

1. Folkman J. Tumor angiogenesis. Adv. Cancer Res. 43:1985;175-203.
2. Srivastava A., Laidler P., Davies R.P., Horgan K., Hughes L. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. Am. J. Pathol. 133:1988;419-423.
3. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1-7.
4. Macchiarini P., Fontanini G., Hardin M.J., Squartini F., Angeletti G.A. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet. 340:1992;145-146.
5. Wakui S., Furusato M., Itoh T., Sasaki H., Akiyama A., Kinoshita I., Asano K., Tokuda T., Aizawa S., Ushigome S. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J. Pathol. 168:1992;257-262.
6. Weidner N., Carroll P.R., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143:1993;401-409.
7. Folkman J., Haudenschild C. Angiogenesis in vitro. Nature. 288:1980;551-556.
8. Ishikawa F., Miyazono K., Hellman U., Drexler H., Wernstedt C., Hagiwara K., Usuki K., Takaku F., Risau W., Heldin C.-H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 338:1989;557-562.
9. Furukawa T., Yoshimura A., Sumizawa T., Haraguchi M., Akiyama S. Angiogenic factor. Nature. 356:1992;668.
10. Sumizawa T., Furukawa T., Haraguchi M., Yoshimura A., Takeyasu A., Ishizawa M., Yamada Y., Akiyama S. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J. Biochem. 114:1993;9-14.
11. Haraguchi M., Miyadera K., Uemura K., Sumizawa T., Furukawa T., Yamada K., Akiyama S. Angiogenic activity of enzymes. Nature. 368:1994;198.
12. Miyadera K., Sumizawa T., Haraguchi M., Yoshida H., Konstanty W., Yamada Y., Akiyama S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res. 55:1995;1687-1690.
13. Yoshimura A., Kuwazuru Y., Furukawa T., Yoshida H., Yamada K., Akiyama S. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocyte, reticulocytes and tumors. Biochim. Biophys. Acta. 1034:1990;107-113.
14. FIGO, News, Int. J. Gynecol. Obstet. 28 (1989) 189-193.
15. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;315-323.
16. Nishida M., Hino A., Mori K., Matsumoto T., Yoshikubo T., Ishitsuka H. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol. Pharm. Bull. 19:1996;1407-1411.
17. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
18. Hagiwara K., Stenman G., Honda H., Sahlin P., Andersson A., Miyazono K., Heldin C.-H., Ishikawa F., Takaku F. Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. Mol. Cell Biol. 11:1991;2125-2132.
19. Arcari P., Martinelli R., Salvatore F. The complete sequences of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res. 12:1984;9179-9189.
20. Denekamp J. Vascular as a target for tumor therapy. Prog. Appl. Microcirc. 4:1984;28-38.
21. O'Brien T., Cranston D., Fuggle S., Bicknell R., Harris A.L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 55:1995;510-513.
22. J. Fujimoto, M. Hori, S. Ichigo, T. Tamaya, Expression of basic fibroblast growth factor and its mRNA in advanced ovarian cancers, Eur. J. Gynaecol. Oncol. 18 (1997) 349-352.
23. Ingber D., Fijita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., Folkman J. Synthetic analog of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature. 348:1990;555-557.
24. Folkman J., Ingber D.E. Angiostatic steroids. Ann. Surg. 206:1987;374-383.
25. Fujimoto J., Hosoda S., Fujita H. Okada Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. Invas. Metastas. 9:1989;269-277.